Celonic AG, the Swiss biologics contract development and manufacturing organization, has appointed Soenke Brunswieck as Vice President Cell & Gene Therapy to establish Celonic`s new …
Initial clinical successes with cell and gene therapies have driven significant investment in these next-generation technologies by both large bio/pharma companies and start-up specialist firms …
On the occasion of its 20th anniversary, the Swiss Biotech Association launches Swiss Biotech Success Stories in recognition of the industry’s many accomplishments. Swiss Biotech …
Synyi will use the fund to develop medical natural language processing, medical data governance and machine learning. Venture capital firm GGV Capital has led a …
The ministry plans to carry out this medical artificial intelligence project over the course of three years. The South Korean government plans to invest 35.7 …
The deal aims to distribute Cellmid’s évolis and anti-aging hair care products in the Peoples Republic of China Australia based Cellmid has recently announced that …
Haselmeier, a Swiss-based developer and manufacturer of innovative self-injection devices, and Common Sensing, a Cambridge-based smart injector monitoring and support solutions company, today announced a …
It hasn’t been the prettiest first quarter for drugmakers. Sanofi’s revenue fell, as did confidence in one of the company’s key growth drivers. Allergan discussed …
In a recent paper on “Value-Based Pricing for Drugs”, authors Anna Kaltenboeck and Peter B. Bach of the Memorial Sloan Kettering Cancer Center discuss the …
ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) announces that its U.S.-based partner and licensee Integrated BioTherapeutics (“IBT”) has initiated sales and marketing of its first ExpreS2-based product. The …
Brief: Allergan CEO Brent Saunders said Monday the Irish pharma is considering a wide range of business options, including further divestitures or a split of …
Brief: United Therapeutics announced Monday morning that it will acquire competitor SteadyMed for $4.46 per share in cash upfront and another $2.63 per share in …
Brief: Spark Therapeutics has sold a priority review voucher (PRV) to Jazz Pharmaceuticals for $110 million, according to a Monday disclosure. While details were scant, …
Wickham Laboratories CEO, Dr John McKenzie, will be presenting at the Cleanroom Technology Conference on the 16th May at 2:30PM, at the National Conference Centre …
On April 23, 2018, Pfizer announced that it received a complete response letter (CRL) from FDA in response to the biologics license application (BLA) for …
Athyrium Capital Management partners with VIVUS to support next growth phase New capital to be used to facilitate the acquisition of PANCREAZE® (pancrelipase) VIVUS, Inc. …
WuXi Biologics will invest €325m in company’s first site outside of China A major Chinese biopharmaceutical company is to create 400 jobs with a €325 …
Funding earmarked for US market penetration and development of groundbreaking upstream bioconjugation approach ADC Biotechnology (ADC Bio), announces that it has secured £1.14 million in …
Copley Scientific, a leading manufacturer of laboratory testing equipment, has introduced a new Vertical Diffusion Cell (VDC) for efficient in vitro skin permeation studies. The …
New vessel for ambr® 250 ht system will enable cost-effective, scalable process development of vaccines in cell culture Premieres at the BPI European Summit in …
